India to increase Covaxin production to 100 million doses per month by September

Credit: IndiaTimes- Published 3 weeks ago
The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As part of its efforts to accelerate the development and production of indigenous Covid vaccines, the government is providing financial support as grant to the tune of...

You are here


💡 newsR Knowledge: Other News Mentions

BBV152

Vaccine against COVID-19
From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum..
Credit: IndiaTimes - Published 1 minute ago



Bharat Biotech

Indian biotechnology company and vaccine manufacturer
The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid..
Credit: IndiaTimes - Published 6 days ago

"The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in..
Credit: IndiaTimes - Published 6 days ago



Related videos from verified sources

Dinaosaur bones found in Meghalaya | 100 million years old | Oneindia News 01:44
Credit: Oneindia - Published 4 days ago 


Tripura needs 32 lakh vaccine doses for 100% vaccination of people between 18-44 years 01:42
Credit: ANI - Published 1 week ago 


‘India supplied 64 million Covid vaccine doses to 84 countries’: Harsh Vardhan 02:26
Credit: HT Digital Content - Published on March 31, 2021 


Related news from verified sources

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As...
3 weeks ago • IndiaTimes

The production of indigenously developed Covid-19 vaccine Covaxin will be ramped up significantly and increased to 10 crore doses per month by September, the...
3 weeks ago • IndiaTimes

The Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19...
on April 7, 2021 • IndiaTimes

You might like